Yumanity Therapeutics Inc (YMTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | YMTX | AZN | AMGN | GILD | VRTX |
| Company | Yumanity Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.6300 | 90.29 | 326.27 | 121.24 | 449.74 |
| High | 1.8900 | 90.66 | 328.24 | 121.50 | 452.63 |
| Low | 1.4000 | 90.22 | 325.02 | 120.96 | 449.00 |
| Latest | 1.8900 | 90.43 | 325.38 | 121.31 | 450.33 |
| Change | +0.1500 | +0.57 | -0.63 | -0.05 | +0.81 |
| % Change | +8.62% | +0.63% | -0.19% | -0.04% | +0.18% |
| Volume | 697,400 | 177,169 | 188,907 | 144,904 | 29,461 |
| 20-Day Average Volume | 312,450 | 5,534,781 | 2,751,995 | 6,793,696 | 1,327,464 |
| Previous Close | 1.7400 | 89.86 | 326.01 | 121.36 | 449.52 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.8773 | 90.92 | 331.06 | 123.06 | 441.85 |
| 20-Day Raw Stochastic | 59.76% | 39.25% | 43.48% | 29.68% | 72.27% |
| 20-Day Relative Strength | 52.61 | 55.95 | 53.34 | 49.27 | 58.10 |
| Weighted Alpha | -37.50 | +40.72 | +24.44 | +28.01 | +12.65 |
| Today's Opinion | 96% Buy | 88% Buy | 72% Buy | 56% Buy | 72% Buy |
| Previous Opinion | 64% Buy | 88% Buy | 72% Buy | 56% Buy | 56% Buy |
| Last Month's Opinion | 88% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.03% since 12/09/22 | +0.35% since 12/11/25 | +3.08% since 12/11/25 | -1.55% since 12/11/25 | +1.29% since 12/11/25 |
| Low | 1.4000 on 12/16/22 | 89.28 on 12/12/25 | 315.19 on 12/12/25 | 118.17 on 12/16/25 | 444.81 on 12/12/25 |
| High | 2.0900 on 12/13/22 | 91.79 on 12/15/25 | 330.04 on 12/17/25 | 123.63 on 12/12/25 | 459.05 on 12/16/25 |
| 1-Month | |||||
| %Chg | +3.95% since 11/16/22 | +1.18% since 11/18/25 | -4.89% since 11/18/25 | -4.63% since 11/18/25 | +3.71% since 11/18/25 |
| Low | 1.4000 on 12/16/22 | 88.41 on 11/20/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 418.53 on 11/19/25 |
| High | 2.2200 on 12/08/22 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +13.86% since 09/16/22 | +17.57% since 09/18/25 | +18.61% since 09/18/25 | +6.75% since 09/18/25 | +16.68% since 09/18/25 |
| Low | 1.4000 on 12/16/22 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 2.2200 on 12/08/22 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +20.38% since 06/16/22 | +28.05% since 06/18/25 | +12.96% since 06/18/25 | +12.31% since 06/18/25 | +0.73% since 06/18/25 |
| Low | 1.4000 on 12/16/22 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 2.2200 on 12/08/22 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 20,518 | 278,694,144 | 175,550,208 | 150,568,928 | 114,051,760 |
| Shares Outstanding, K | 10,856 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 8,040,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -39,500,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 1,400,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -3,360,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.32 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.31 on 11/14/22 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/23/23 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.99 | 14.94 | 14.50 | 29.72 |